Patent grants in US as Elasmogen moves closer to commercialization and clinical development.

The drugs were designed to keep cancer cells at bay by preventing their growth, survival and spread. Yet, after clinical trials, they left scientists scratching their heads and drug developers watching their investments succumb to cancer’s latest triumph.

A new study by Dana-Farber Cancer Institute investigators demonstrates that vitamin D can protect some people with colorectal cancer by perking up the immune system’s vigilance against tumor cells.

Research at the University of Adelaide is pointing towards a possible prevention of severe gut problems for patients undergoing chemotherapy for cancer.

The early registration dealine for the AACR Annual Meeting 2015 is this Friday!  Take advantage of the lowest prices available for this meeting that covers the full spectrum of cancer research–including basic, translational, clinical, and population research–through a variety of session formats. You will join more than 18,000 fellow attendees, be among the best and brightest researchers and clinicians in cancer research, and have the opportunity to network and form collaborations with colleagues from more than 70 countries.

‘Zombie’ method also hardens biostructures for mass production.

University of Chicago to establish Genomic Data Commons.

Findings pave way for research that focuses on detection and prevention.

The new method lets researchers identify weak and previously undetectable interactions between proteins inside living cells.

University of Arkansas for Medical Sciences (UAMS) researcher Vladimir Zharov, Ph.D., D.Sc., recently was awarded a  $1.5 million grant by the National Institutes of Health to investigate the use of nanoparticles in cancer diagnosis and treatment.